25 XP   0   0   10

Microbix Biosystems Inc.
Buy, Hold or Sell?

Let's analyse Microbix together

PenkeI guess you are interested in Microbix Biosystems Inc.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Microbix Biosystems Inc.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Microbix Biosystems Inc.

I send you an email if I find something interesting about Microbix Biosystems Inc..

Quick analysis of Microbix (30 sec.)










What can you expect buying and holding a share of Microbix? (30 sec.)

How much money do you get?

How much money do you get?
C$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
C$0.20
Expected worth in 1 year
C$0.23
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
C$0.03
Return On Investment
8.3%

For what price can you sell your share?

Current Price per Share
C$0.37
Expected price per share
C$0.33 - C$0.37
How sure are you?
50%

1. Valuation of Microbix (5 min.)




Live pricePrice per Share (EOD)

C$0.37

Intrinsic Value Per Share

C$0.09 - C$0.77

Total Value Per Share

C$0.29 - C$0.97

2. Growth of Microbix (5 min.)




Is Microbix growing?

Current yearPrevious yearGrowGrow %
How rich?$20m$17.8m$165.6k0.9%

How much money is Microbix making?

Current yearPrevious yearGrowGrow %
Making money$646.8k-$201.5k$848.3k131.2%
Net Profit Margin14.5%-13.3%--

How much money comes from the company's main activities?

3. Financial Health of Microbix (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#600 / 1031

Most Revenue
#367 / 1031

Most Profit
#143 / 1031

Most Efficient
#103 / 1031

What can you expect buying and holding a share of Microbix? (5 min.)

Welcome investor! Microbix's management wants to use your money to grow the business. In return you get a share of Microbix.

What can you expect buying and holding a share of Microbix?

First you should know what it really means to hold a share of Microbix. And how you can make/lose money.

Speculation

The Price per Share of Microbix is C$0.365. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Microbix.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Microbix, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is C$0.20. Based on the TTM, the Book Value Change Per Share is C$0.01 per quarter. Based on the YOY, the Book Value Change Per Share is C$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is C$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Microbix.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 C$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per Share
Usd Eps0.013.6%0.011.4%0.00-0.2%0.000.1%0.00-0.4%
Usd Book Value Change Per Share0.013.9%0.011.5%0.000.9%0.001.3%0.000.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.013.9%0.011.5%0.000.9%0.001.3%0.000.8%
Usd Price Per Share0.29-0.27-0.37-0.31-0.29-
Price to Earnings Ratio5.42-108.46-2.10-18.72-645.22-
Price-to-Total Gains Ratio20.05-18.00-36.80--572.47--338.21-
Price to Book Ratio1.96-2.11-2.94-3.95-3.98-
Price-to-Total Gains Ratio20.05-18.00-36.80--572.47--338.21-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.2687495
Number of shares3720
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.010.00
Usd Total Gains Per Share0.010.00
Gains per Quarter (3720 shares)20.7117.01
Gains per Year (3720 shares)82.8468.03
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10837306858
201661560136126
302492390204194
403313220272262
504144050340330
604974880408398
705805710476466
806636540544534
907467370612602
1008288200680670

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%9.03.00.075.0%11.09.00.055.0%23.017.00.057.5%38.067.04.034.9%
Book Value Change Per Share3.01.00.075.0%10.02.00.083.3%13.07.00.065.0%28.012.00.070.0%56.050.03.051.4%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.0109.00.0%
Total Gains per Share3.01.00.075.0%10.02.00.083.3%13.07.00.065.0%28.012.00.070.0%56.050.03.051.4%

Fundamentals of Microbix

About Microbix Biosystems Inc.

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

Fundamental data was last updated by Penke on 2024-03-10 20:23:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Microbix Biosystems Inc..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Microbix earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Microbix to the Biotechnology industry mean.
  • A Net Profit Margin of 29.2% means that $0.29 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Microbix Biosystems Inc.:

  • The MRQ is 29.2%. The company is making a huge profit. +2
  • The TTM is 14.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ29.2%TTM14.5%+14.7%
TTM14.5%YOY-13.3%+27.8%
TTM14.5%5Y-7.6%+22.1%
5Y-7.6%10Y-14.1%+6.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ29.2%-159.2%+188.4%
TTM14.5%-202.3%+216.8%
YOY-13.3%-263.0%+249.7%
5Y-7.6%-452.4%+444.8%
10Y-14.1%-589.0%+574.9%
1.1.2. Return on Assets

Shows how efficient Microbix is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Microbix to the Biotechnology industry mean.
  • 6.7% Return on Assets means that Microbix generated $0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Microbix Biosystems Inc.:

  • The MRQ is 6.7%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 2.4%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ6.7%TTM2.4%+4.3%
TTM2.4%YOY-0.8%+3.2%
TTM2.4%5Y-0.8%+3.1%
5Y-0.8%10Y-1.7%+1.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.7%-12.5%+19.2%
TTM2.4%-12.2%+14.6%
YOY-0.8%-11.2%+10.4%
5Y-0.8%-13.3%+12.5%
10Y-1.7%-14.6%+12.9%
1.1.3. Return on Equity

Shows how efficient Microbix is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Microbix to the Biotechnology industry mean.
  • 9.0% Return on Equity means Microbix generated $0.09 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Microbix Biosystems Inc.:

  • The MRQ is 9.0%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 3.3%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ9.0%TTM3.3%+5.8%
TTM3.3%YOY-1.2%+4.4%
TTM3.3%5Y-2.5%+5.7%
5Y-2.5%10Y-3.6%+1.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.0%-16.0%+25.0%
TTM3.3%-15.8%+19.1%
YOY-1.2%-13.9%+12.7%
5Y-2.5%-18.2%+15.7%
10Y-3.6%-19.1%+15.5%

1.2. Operating Efficiency of Microbix Biosystems Inc..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Microbix is operating .

  • Measures how much profit Microbix makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Microbix to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Microbix Biosystems Inc.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-1.6%+1.6%
TTM-1.6%YOY-3.2%+1.6%
TTM-1.6%5Y-0.5%-1.1%
5Y-0.5%10Y-7.3%+6.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.5%+299.5%
TTM-1.6%-208.5%+206.9%
YOY-3.2%-280.2%+277.0%
5Y-0.5%-459.9%+459.4%
10Y-7.3%-596.9%+589.6%
1.2.2. Operating Ratio

Measures how efficient Microbix is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.95 means that the operating costs are $0.95 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Microbix Biosystems Inc.:

  • The MRQ is 0.954. The company is less efficient in keeping operating costs low.
  • The TTM is 1.380. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.954TTM1.380-0.426
TTM1.380YOY1.047+0.333
TTM1.3805Y1.024+0.356
5Y1.02410Y0.989+0.035
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9542.817-1.863
TTM1.3803.181-1.801
YOY1.0473.609-2.562
5Y1.0245.554-4.530
10Y0.9897.396-6.407

1.3. Liquidity of Microbix Biosystems Inc..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Microbix is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 8.53 means the company has $8.53 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Microbix Biosystems Inc.:

  • The MRQ is 8.531. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.084. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ8.531TTM6.084+2.447
TTM6.084YOY7.277-1.193
TTM6.0845Y4.018+2.066
5Y4.01810Y2.755+1.262
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.5313.987+4.544
TTM6.0844.440+1.644
YOY7.2775.569+1.708
5Y4.0186.158-2.140
10Y2.7556.492-3.737
1.3.2. Quick Ratio

Measures if Microbix is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Microbix to the Biotechnology industry mean.
  • A Quick Ratio of 1.37 means the company can pay off $1.37 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Microbix Biosystems Inc.:

  • The MRQ is 1.370. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 2.415. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.370TTM2.415-1.045
TTM2.415YOY5.231-2.816
TTM2.4155Y2.208+0.207
5Y2.20810Y1.407+0.801
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3703.653-2.283
TTM2.4154.158-1.743
YOY5.2315.515-0.284
5Y2.2086.012-3.804
10Y1.4076.206-4.799

1.4. Solvency of Microbix Biosystems Inc..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Microbix assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Microbix to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.26 means that Microbix assets are financed with 25.8% credit (debt) and the remaining percentage (100% - 25.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Microbix Biosystems Inc.:

  • The MRQ is 0.258. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.301. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.258TTM0.301-0.043
TTM0.301YOY0.266+0.035
TTM0.3015Y0.386-0.085
5Y0.38610Y0.402-0.016
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2580.336-0.078
TTM0.3010.330-0.029
YOY0.2660.267-0.001
5Y0.3860.367+0.019
10Y0.4020.378+0.024
1.4.2. Debt to Equity Ratio

Measures if Microbix is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Microbix to the Biotechnology industry mean.
  • A Debt to Equity ratio of 34.8% means that company has $0.35 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Microbix Biosystems Inc.:

  • The MRQ is 0.348. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.433. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.348TTM0.433-0.085
TTM0.433YOY0.363+0.070
TTM0.4335Y0.686-0.253
5Y0.68610Y0.709-0.023
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3480.376-0.028
TTM0.4330.398+0.035
YOY0.3630.334+0.029
5Y0.6860.431+0.255
10Y0.7090.476+0.233

2. Market Valuation of Microbix Biosystems Inc.

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Microbix generates.

  • Above 15 is considered overpriced but always compare Microbix to the Biotechnology industry mean.
  • A PE ratio of 5.42 means the investor is paying $5.42 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Microbix Biosystems Inc.:

  • The EOD is 5.075. Based on the earnings, the company is cheap. +2
  • The MRQ is 5.422. Based on the earnings, the company is cheap. +2
  • The TTM is 108.461. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD5.075MRQ5.422-0.348
MRQ5.422TTM108.461-103.039
TTM108.461YOY2.104+106.358
TTM108.4615Y18.718+89.743
5Y18.71810Y645.223-626.505
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD5.075-2.697+7.772
MRQ5.422-2.422+7.844
TTM108.461-2.709+111.170
YOY2.104-4.116+6.220
5Y18.718-6.257+24.975
10Y645.223-6.478+651.701
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Microbix Biosystems Inc.:

  • The EOD is 9.568. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 10.224. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 0.451. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD9.568MRQ10.224-0.655
MRQ10.224TTM0.451+9.773
TTM0.451YOY4.395-3.944
TTM0.4515Y-0.492+0.943
5Y-0.49210Y-105.583+105.091
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD9.568-3.344+12.912
MRQ10.224-2.939+13.163
TTM0.451-3.486+3.937
YOY4.395-5.592+9.987
5Y-0.492-8.464+7.972
10Y-105.583-8.872-96.711
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Microbix is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.96 means the investor is paying $1.96 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Microbix Biosystems Inc.:

  • The EOD is 1.831. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.956. Based on the equity, the company is underpriced. +1
  • The TTM is 2.107. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.831MRQ1.956-0.125
MRQ1.956TTM2.107-0.151
TTM2.107YOY2.945-0.838
TTM2.1075Y3.950-1.843
5Y3.95010Y3.979-0.029
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.8312.198-0.367
MRQ1.9562.042-0.086
TTM2.1072.121-0.014
YOY2.9452.907+0.038
5Y3.9503.682+0.268
10Y3.9794.114-0.135
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Microbix Biosystems Inc. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0190.008+157%0.004+335%0.006+213%0.004+397%
Book Value Per Share--0.1990.176+13%0.172+16%0.121+65%0.110+81%
Current Ratio--8.5316.084+40%7.277+17%4.018+112%2.755+210%
Debt To Asset Ratio--0.2580.301-14%0.266-3%0.386-33%0.402-36%
Debt To Equity Ratio--0.3480.433-20%0.363-4%0.686-49%0.709-51%
Dividend Per Share----0%-0%-0%-0%
Eps--0.0180.007+165%-0.001+104%0.000+4338%-0.002+110%
Free Cash Flow Per Share--0.0100.000+3598%0.002+467%0.000+12872%-0.002+122%
Free Cash Flow To Equity Per Share--0.0090.001+1075%0.003+165%0.004+112%0.002+330%
Gross Profit Margin--1.0001.554-36%0.809+24%1.213-18%-5.931+693%
Intrinsic Value_10Y_max--0.766--------
Intrinsic Value_10Y_min--0.089--------
Intrinsic Value_1Y_max--0.015--------
Intrinsic Value_1Y_min---0.005--------
Intrinsic Value_3Y_max--0.093--------
Intrinsic Value_3Y_min---0.004--------
Intrinsic Value_5Y_max--0.226--------
Intrinsic Value_5Y_min--0.011--------
Market Cap49840750.000-7%53254645.47051236149.335+4%71386935.495-25%58830439.847-9%53806463.673-1%
Net Profit Margin--0.2920.145+101%-0.133+146%-0.076+126%-0.141+148%
Operating Margin----0.0160%-0.0320%-0.0050%-0.0730%
Operating Ratio--0.9541.380-31%1.047-9%1.024-7%0.989-4%
Pb Ratio1.831-7%1.9562.107-7%2.945-34%3.950-50%3.979-51%
Pe Ratio5.075-7%5.422108.461-95%2.104+158%18.718-71%645.223-99%
Price Per Share0.365-7%0.3900.368+6%0.505-23%0.419-7%0.388+0%
Price To Free Cash Flow Ratio9.568-7%10.2240.451+2167%4.395+133%-0.492+105%-105.583+1133%
Price To Total Gains Ratio18.768-7%20.05418.003+11%36.797-46%-572.472+2955%-338.209+1787%
Quick Ratio--1.3702.415-43%5.231-74%2.208-38%1.407-3%
Return On Assets--0.0670.024+181%-0.008+113%-0.008+111%-0.017+126%
Return On Equity--0.0900.033+177%-0.012+113%-0.025+127%-0.036+140%
Total Gains Per Share--0.0190.008+157%0.004+335%0.006+213%0.004+397%
Usd Book Value--20046176.88318013318.114+11%17847654.111+12%12495610.680+60%11229066.333+79%
Usd Book Value Change Per Share--0.0140.006+157%0.003+335%0.005+213%0.003+397%
Usd Book Value Per Share--0.1470.130+13%0.126+16%0.089+65%0.081+81%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0130.005+165%-0.001+104%0.000+4338%-0.001+110%
Usd Free Cash Flow--958848.1486898.947+13798%189751.505+405%5938.738+16046%-207763.354+122%
Usd Free Cash Flow Per Share--0.0070.000+3598%0.001+467%0.000+12872%-0.002+122%
Usd Free Cash Flow To Equity Per Share--0.0060.001+1075%0.002+165%0.003+112%0.001+330%
Usd Market Cap36697744.225-7%39211395.46037725176.755+4%52562200.605-25%43316852.859-9%39617699.203-1%
Usd Price Per Share0.269-7%0.2870.271+6%0.372-23%0.309-7%0.286+0%
Usd Profit--1807895.558646799.974+180%-201540.772+111%7952.298+22634%-200452.779+111%
Usd Revenue--6190724.9894127069.368+50%3078233.395+101%3094974.170+100%2468177.369+151%
Usd Total Gains Per Share--0.0140.006+157%0.003+335%0.005+213%0.003+397%
 EOD+4 -4MRQTTM+29 -4YOY+26 -75Y+27 -610Y+28 -5

3.2. Fundamental Score

Let's check the fundamental score of Microbix Biosystems Inc. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-155.075
Price to Book Ratio (EOD)Between0-11.831
Net Profit Margin (MRQ)Greater than00.292
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.370
Current Ratio (MRQ)Greater than18.531
Debt to Asset Ratio (MRQ)Less than10.258
Debt to Equity Ratio (MRQ)Less than10.348
Return on Equity (MRQ)Greater than0.150.090
Return on Assets (MRQ)Greater than0.050.067
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of Microbix Biosystems Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.453
Ma 20Greater thanMa 500.382
Ma 50Greater thanMa 1000.393
Ma 100Greater thanMa 2000.364
OpenGreater thanClose0.370
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CAD. All numbers in thousands.

Summary
Total Assets36,707
Total Liabilities9,481
Total Stockholder Equity27,226
 As reported
Total Liabilities 9,481
Total Stockholder Equity+ 27,226
Total Assets = 36,707

Assets

Total Assets36,707
Total Current Assets23,701
Long-term Assets13,005
Total Current Assets
Cash And Cash Equivalents 12,783
Net Receivables 3,807
Inventory 6,145
Other Current Assets 911
Total Current Assets  (as reported)23,701
Total Current Assets  (calculated)23,645
+/- 56
Long-term Assets
Property Plant Equipment 8,697
Intangible Assets 4,308
Long-term Assets Other 0
Long-term Assets  (as reported)13,005
Long-term Assets  (calculated)13,005
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,778
Long-term Liabilities6,703
Total Stockholder Equity27,226
Total Current Liabilities
Short Long Term Debt 111
Total Current Liabilities  (as reported)2,778
Total Current Liabilities  (calculated)111
+/- 2,667
Long-term Liabilities
Long term Debt 5,751
Capital Lease Obligations Min Short Term Debt816
Long-term Liabilities Other 292
Long-term Liabilities  (as reported)6,703
Long-term Liabilities  (calculated)6,858
+/- 156
Total Stockholder Equity
Total Stockholder Equity (as reported)27,226
Total Stockholder Equity (calculated)0
+/- 27,226
Other
Capital Stock48,994
Common Stock Shares Outstanding 136,550
Net Invested Capital 33,087
Net Working Capital 20,923
Property Plant and Equipment Gross 17,430



Balance Sheet

Currency in CAD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-31
> Total Assets 
2,800
2,800
9,100
9,100
8,600
7,700
7,600
8,400
7,300
6,600
6,200
2,700
2,600
2,700
2,900
2,906
3,010
3,116
3,129
2,958
2,746
2,674
2,701
2,721
3,073
2,874
2,936
2,978
2,719
3,017
3,074
3,375
3,506
3,703
3,862
3,950
4,138
4,970
4,926
3,957
3,809
4,028
6,090
5,802
11,926
11,545
11,444
14,604
14,103
14,570
13,938
14,089
13,453
14,311
13,516
14,312
13,386
16,998
16,964
13,811
13,519
13,872
13,403
13,509
12,732
13,013
12,771
12,716
12,442
14,995
16,018
17,999
18,842
22,008
22,239
23,547
23,533
24,151
25,105
25,247
24,884
25,845
26,203
26,438
27,434
26,866
28,180
19,310
19,928
20,304
20,322
19,630
19,756
20,692
20,485
15,598
16,287
17,956
25,864
28,829
31,226
32,947
33,296
33,145
32,694
33,194
34,295
35,653
36,707
36,70735,65334,29533,19432,69433,14533,29632,94731,22628,82925,86417,95616,28715,59820,48520,69219,75619,63020,32220,30419,92819,31028,18026,86627,43426,43826,20325,84524,88425,24725,10524,15123,53323,54722,23922,00818,84217,99916,01814,99512,44212,71612,77113,01312,73213,50913,40313,87213,51913,81116,96416,99813,38614,31213,51614,31113,45314,08913,93814,57014,10314,60411,44411,54511,9265,8026,0904,0283,8093,9574,9264,9704,1383,9503,8623,7033,5063,3753,0743,0172,7192,9782,9362,8743,0732,7212,7012,6742,7462,9583,1293,1163,0102,9062,9002,7002,6002,7006,2006,6007,3008,4007,6007,7008,6009,1009,1002,8002,800
   > Total Current Assets 
1,900
2,000
8,100
8,000
7,000
5,500
5,500
6,400
5,400
4,800
4,400
1,100
1,000
1,100
1,400
1,456
1,591
1,740
1,770
1,627
1,450
1,407
1,461
1,518
1,868
1,681
1,772
1,814
1,584
1,880
1,957
2,269
2,419
2,552
2,648
2,388
2,378
3,029
2,495
1,945
1,775
2,014
2,515
2,294
7,958
7,409
5,779
5,612
3,727
3,286
2,443
2,759
2,136
3,049
2,344
3,190
2,370
2,900
2,988
3,087
2,893
3,347
2,959
3,137
2,447
2,788
2,648
2,638
2,373
4,415
4,073
4,707
4,481
5,444
4,882
5,788
5,109
5,366
5,950
5,661
5,042
5,639
5,708
6,162
6,512
5,843
6,959
6,067
6,793
7,330
7,387
6,452
6,161
7,094
6,700
6,493
7,136
8,840
16,805
19,094
21,548
23,127
23,476
22,408
22,066
22,309
23,499
22,302
23,701
23,70122,30223,49922,30922,06622,40823,47623,12721,54819,09416,8058,8407,1366,4936,7007,0946,1616,4527,3877,3306,7936,0676,9595,8436,5126,1625,7085,6395,0425,6615,9505,3665,1095,7884,8825,4444,4814,7074,0734,4152,3732,6382,6482,7882,4473,1372,9593,3472,8933,0872,9882,9002,3703,1902,3443,0492,1362,7592,4433,2863,7275,6125,7797,4097,9582,2942,5152,0141,7751,9452,4953,0292,3782,3882,6482,5522,4192,2691,9571,8801,5841,8141,7721,6811,8681,5181,4611,4071,4501,6271,7701,7401,5911,4561,4001,1001,0001,1004,4004,8005,4006,4005,5005,5007,0008,0008,1002,0001,900
       Cash And Cash Equivalents 
1,100
300
6,300
6,100
5,000
3,000
1,900
1,700
900
800
400
200
200
300
500
552
510
502
511
694
612
474
298
557
878
429
556
527
498
631
788
1,272
1,353
1,577
1,509
1,255
1,262
1,559
1,066
401
100
108
548
638
6,241
4,469
3,390
3,407
1,045
801
774
588
121
775
99
16
193
149
195
125
188
494
563
228
175
125
53
260
208
1,150
452
547
791
1,117
0
104
66
7
5
5
2
33
164
54
51
92
56
44
276
25
14
96
70
168
402
93
417
1,545
7,507
9,986
10,495
12,201
14,163
13,488
12,425
11,722
13,409
11,606
12,783
12,78311,60613,40911,72212,42513,48814,16312,20110,4959,9867,5071,545417934021687096142527644569251541643325576610401,1177915474521,1502082605312517522856349418812519514919316997751215887748011,0453,4073,3904,4696,2416385481081004011,0661,5591,2621,2551,5091,5771,3531,2727886314985275564298785572984746126945115025105525003002002004008009001,7001,9003,0005,0006,1006,3003001,100
       Net Receivables 
400
800
1,100
700
500
1,200
1,900
1,100
800
300
400
400
300
300
400
447
659
748
762
452
314
418
704
498
413
668
685
789
617
692
541
460
571
464
586
501
488
745
599
629
713
841
890
822
878
1,249
1,386
1,207
1,779
1,580
788
1,123
770
982
864
1,983
751
1,275
1,223
1,501
948
1,134
605
1,513
720
1,220
1,271
1,230
1,076
1,863
1,856
2,285
1,758
2,224
2,026
1,842
897
1,605
2,302
2,204
1,304
1,547
1,016
1,487
1,726
1,038
2,028
1,406
1,078
1,922
1,917
1,777
1,257
2,008
1,304
1,887
1,896
2,124
4,180
4,206
5,560
4,578
2,518
3,089
2,895
3,184
3,403
4,120
3,807
3,8074,1203,4033,1842,8953,0892,5184,5785,5604,2064,1802,1241,8961,8871,3042,0081,2571,7771,9171,9221,0781,4062,0281,0381,7261,4871,0161,5471,3042,2042,3021,6058971,8422,0262,2241,7582,2851,8561,8631,0761,2301,2711,2207201,5136051,1349481,5011,2231,2757511,9838649827701,1237881,5801,7791,2071,3861,2498788228908417136295997454885015864645714605416926177896856684134987044183144527627486594474003003004004003008001,1001,9001,2005007001,100800400
       Other Current Assets 
400
500
300
600
600
500
600
500
600
600
500
100
100
0
100
46
32
97
111
91
86
99
83
34
53
117
92
46
37
49
50
45
52
81
87
77
52
72
116
71
63
112
98
78
63
881
137
132
122
125
83
113
62
126
92
100
88
117
104
178
53
94
103
148
102
101
71
76
88
304
368
276
280
184
416
216
126
91
68
56
62
89
112
153
94
93
172
170
115
161
116
99
25
128
159
220
293
256
295
495
612
1,005
1,496
546
715
550
0
0
911
911005507155461,4961,00561249529525629322015912825991161611151701729394153112896256689112621641618428027636830488767110110214810394531781041178810092126621138312512213213788163789811263711167252778781524550493746921175334839986911119732461000100100500600600500600500600600300500400
   > Long-term Assets 
900
800
1,000
1,100
1,600
2,200
2,100
2,000
1,900
1,800
1,800
1,600
1,600
1,600
1,500
1,450
1,419
1,376
1,359
1,331
1,296
1,267
1,240
1,203
1,205
1,193
1,165
1,164
1,135
1,137
1,117
1,106
1,087
1,151
1,214
1,562
1,760
1,941
2,431
2,012
2,034
2,014
3,575
3,508
3,968
4,136
5,665
8,991
10,377
11,284
11,495
11,330
11,318
11,261
11,172
11,122
11,016
14,098
13,976
10,724
10,626
10,525
10,444
10,372
10,284
10,225
10,124
10,078
10,069
10,580
11,945
13,292
14,361
16,564
17,357
17,759
18,424
18,785
19,156
19,586
19,841
20,206
20,495
20,276
20,922
21,023
21,221
13,243
13,135
12,975
12,935
13,177
13,595
13,598
13,785
9,105
9,151
9,116
9,059
9,735
9,678
9,820
9,821
10,737
10,628
10,885
10,796
13,351
13,005
13,00513,35110,79610,88510,62810,7379,8219,8209,6789,7359,0599,1169,1519,10513,78513,59813,59513,17712,93512,97513,13513,24321,22121,02320,92220,27620,49520,20619,84119,58619,15618,78518,42417,75917,35716,56414,36113,29211,94510,58010,06910,07810,12410,22510,28410,37210,44410,52510,62610,72413,97614,09811,01611,12211,17211,26111,31811,33011,49511,28410,3778,9915,6654,1363,9683,5083,5752,0142,0342,0122,4311,9411,7601,5621,2141,1511,0871,1061,1171,1371,1351,1641,1651,1931,2051,2031,2401,2671,2961,3311,3591,3761,4191,4501,5001,6001,6001,6001,8001,8001,9002,0002,1002,2001,6001,1001,000800900
       Property Plant Equipment 
600
500
700
800
1,400
2,000
1,900
1,800
1,700
1,700
1,600
1,500
1,500
1,400
1,400
1,367
1,346
1,313
1,306
1,287
1,256
1,230
1,206
1,182
1,181
1,169
1,141
1,147
1,120
1,123
1,108
1,100
1,084
1,150
1,210
1,280
1,484
1,670
1,618
1,753
1,779
1,765
1,832
1,825
1,771
1,979
4,054
4,634
6,043
6,710
6,943
6,799
6,811
6,778
6,713
6,687
6,605
6,511
6,413
6,384
6,311
6,233
6,176
6,128
6,064
6,028
5,951
5,929
5,943
6,355
7,562
8,752
9,796
11,735
12,712
11,867
12,024
12,173
12,209
12,252
12,214
12,170
12,309
12,212
12,771
12,861
13,090
6,647
6,573
6,539
6,534
6,650
7,103
7,139
7,361
7,363
7,443
7,388
7,368
8,083
8,064
8,245
8,284
8,906
8,835
9,131
9,081
8,928
8,697
8,6978,9289,0819,1318,8358,9068,2848,2458,0648,0837,3687,3887,4437,3637,3617,1397,1036,6506,5346,5396,5736,64713,09012,86112,77112,21212,30912,17012,21412,25212,20912,17312,02411,86712,71211,7359,7968,7527,5626,3555,9435,9295,9516,0286,0646,1286,1766,2336,3116,3846,4136,5116,6056,6876,7136,7786,8116,7996,9436,7106,0434,6344,0541,9791,7711,8251,8321,7651,7791,7531,6181,6701,4841,2801,2101,1501,0841,1001,1081,1231,1201,1471,1411,1691,1811,1821,2061,2301,2561,2871,3061,3131,3461,3671,4001,4001,5001,5001,6001,7001,7001,8001,9002,0001,400800700500600
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
100
0
0
0
18
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
279
273
268
262
257
252
246
241
1,682
2,197
2,157
1,611
4,358
4,334
0
0
0
0
0
0
4,185
4,161
4,137
4,113
4,090
4,066
4,042
4,018
3,994
3,971
3,947
3,923
3,899
3,875
4,225
4,384
4,053
4,068
4,048
4,181
5,361
5,779
5,893
6,016
6,204
6,347
6,606
6,606
6,484
6,571
6,582
6,551
5,016
4,982
4,947
4,912
4,959
4,924
4,890
4,855
1,742
1,707
1,729
1,690
1,652
1,613
1,575
1,537
1,498
1,460
1,422
1,383
4,423
4,308
4,3084,4231,3831,4221,4601,4981,5371,5751,6131,6521,6901,7291,7071,7424,8554,8904,9244,9594,9124,9474,9825,0166,5516,5826,5716,4846,6066,6066,3476,2046,0165,8935,7795,3614,1814,0484,0684,0534,3844,2253,8753,8993,9233,9473,9713,9944,0184,0424,0664,0904,1134,1374,1614,1850000004,3344,3581,6112,1572,1971,68224124625225726226827327900000000000000000001800010000000000000
       Long-term Assets Other 
300
300
300
300
200
200
200
200
200
100
200
0
100
200
100
66
73
63
53
43
40
37
33
21
24
24
24
16
15
14
9
6
4
1
3
3
3
3
551
2
2
2
1,502
0
0
0
0
0
0
250
250
250
250
250
250
250
250
250
3,450
250
250
250
250
250
250
250
250
250
250
0
0
222
232
384
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,975
0
0
0
13,598
0
0
0
0
0
0
0
0
0
332
332
332
0
0
0
00033233233200000000013,59800012,975000000000000000384232222002502502502502502502502502502503,4502502502502502502502502502500000001,502222551333314691415162424242133374043536373661002001000200100200200200200200300300300300
> Total Liabilities 
900
900
1,100
1,100
1,200
1,400
1,100
2,000
1,300
1,200
1,200
1,000
900
1,200
1,000
1,143
1,138
1,062
1,003
909
887
781
732
603
1,115
992
1,135
990
881
983
1,314
1,091
1,019
1,067
1,068
1,182
1,393
1,879
2,006
2,479
2,543
2,937
3,009
3,519
3,653
3,892
5,254
6,983
7,055
7,799
7,839
7,677
7,763
7,672
7,985
8,665
7,804
8,670
8,729
8,664
8,652
8,493
8,366
9,385
8,920
9,014
8,875
6,995
6,604
7,907
8,197
8,157
8,229
9,120
9,118
9,870
9,578
9,937
10,760
9,956
9,603
10,256
10,343
11,263
8,998
8,556
9,699
8,957
9,660
9,612
9,781
9,092
9,776
8,744
8,931
8,979
9,243
9,741
9,150
10,273
9,028
9,133
8,551
8,207
9,232
9,829
11,652
11,029
9,481
9,48111,02911,6529,8299,2328,2078,5519,1339,02810,2739,1509,7419,2438,9798,9318,7449,7769,0929,7819,6129,6608,9579,6998,5568,99811,26310,34310,2569,6039,95610,7609,9379,5789,8709,1189,1208,2298,1578,1977,9076,6046,9958,8759,0148,9209,3858,3668,4938,6528,6648,7298,6707,8048,6657,9857,6727,7637,6777,8397,7997,0556,9835,2543,8923,6533,5193,0092,9372,5432,4792,0061,8791,3931,1821,0681,0671,0191,0911,3149838819901,1359921,1156037327818879091,0031,0621,1381,1431,0001,2009001,0001,2001,2001,3002,0001,1001,4001,2001,1001,100900900
   > Total Current Liabilities 
300
400
1,000
1,100
1,300
1,400
1,100
1,400
700
700
700
500
400
500
300
843
875
837
606
759
750
656
645
553
565
492
635
702
588
438
762
532
452
492
484
530
628
731
856
1,028
769
862
923
942
1,054
1,264
1,082
2,266
2,276
2,078
1,799
1,662
1,646
1,522
1,814
2,538
1,581
2,413
2,508
2,403
2,339
2,121
1,919
2,672
2,147
2,184
1,984
1,473
1,103
1,417
1,672
2,640
2,122
3,081
2,946
4,135
4,123
5,041
5,962
5,249
5,036
5,786
6,052
6,516
4,093
3,797
5,001
4,161
4,989
5,062
5,353
4,766
4,868
3,822
4,096
4,090
4,396
4,740
4,180
5,194
4,146
3,566
2,993
2,651
3,489
3,549
5,351
4,350
2,778
2,7784,3505,3513,5493,4892,6512,9933,5664,1465,1944,1804,7404,3964,0904,0963,8224,8684,7665,3535,0624,9894,1615,0013,7974,0936,5166,0525,7865,0365,2495,9625,0414,1234,1352,9463,0812,1222,6401,6721,4171,1031,4731,9842,1842,1472,6721,9192,1212,3392,4032,5082,4131,5812,5381,8141,5221,6461,6621,7992,0782,2762,2661,0821,2641,0549429238627691,0288567316285304844924525327624385887026354925655536456567507596068378758433005004005007007007001,4001,1001,4001,3001,1001,000400300
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
113
150
138
138
100
88
88
63
25
0
0
20
67
70
71
78
98
101
97
92
84
76
64
34
33
26
19
85
82
81
78
405
73
571
633
274
321
289
128
617
517
619
523
120
276
120
127
814
820
904
856
1,458
1,883
2,539
2,640
2,667
2,163
2,514
2,599
2,529
1,406
1,439
1,742
1,464
1,872
2,224
2,697
2,663
2,430
1,311
1,300
1,286
1,296
1,331
1,367
2,656
1,271
786
281
267
224
263
0
0
0
0002632242672817861,2712,6561,3671,3311,2961,2861,3001,3112,4302,6632,6972,2241,8721,4641,7421,4391,4062,5292,5992,5142,1632,6672,6402,5391,8831,45885690482081412712027612052361951761712828932127463357173405788182851926333464768492971019878717067200025638888100138138150113000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,730
6,984
6,889
2,506
1,327
1,352
1,660
1,383
1,793
2,145
2,618
2,582
2,256
1,150
1,138
1,127
1,140
1,177
1,217
2,447
1,071
602
111
111
111
111
111
111
111
1111111111111111111116021,0712,4471,2171,1771,1401,1271,1381,1502,2562,5822,6182,1451,7931,3831,6601,3521,3272,5066,8896,9846,73000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
300
200
500
500
700
800
1,000
1,200
500
500
400
400
300
300
200
393
425
401
396
354
360
281
285
258
452
342
498
564
488
350
470
469
348
361
484
510
561
662
785
951
671
760
826
850
970
1,188
1,017
2,232
2,243
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,965
2,149
2,348
2,842
1,810
1,456
1,913
1,767
1,610
1,594
1,580
1,463
1,581
1,355
1,378
1,488
1,599
2,212
1,736
1,795
1,812
1,495
1,520
1,829
1,783
0
2,517
0
0
002,51701,7831,8291,5201,4951,8121,7951,7362,2121,5991,4881,3781,3551,5811,4631,5801,5941,6101,7671,9131,4561,8102,8422,3482,1491,96500000000000000000000000000000002,2432,2321,0171,1889708508267606719517856625615104843613484694703504885644983424522582852813603543964014253932003003004004005005001,2001,000800700500500200300
       Other Current Liabilities 
0
200
500
600
600
600
100
200
200
200
300
100
100
200
100
450
450
435
210
405
390
375
360
295
0
0
0
0
0
0
204
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,052
1,780
1,577
1,564
1,441
1,736
1,921
1,348
1,736
1,821
2,075
2,018
1,832
1,791
2,056
1,630
1,565
1,461
1,354
827
1,297
1,546
1,826
1,302
2,177
2,090
2,488
2,042
2,078
2,153
1,899
1,965
2,149
2,348
2,842
1,810
1,456
1,913
1,767
1,610
1,594
1,580
1,463
1,581
1,355
1,378
1,488
1,599
2,212
1,736
1,795
1,812
1,495
1,520
1,829
1,783
1,732
2,570
0
0
002,5701,7321,7831,8291,5201,4951,8121,7951,7362,2121,5991,4881,3781,3551,5811,4631,5801,5941,6101,7671,9131,4561,8102,8422,3482,1491,9651,8992,1532,0782,0422,4882,0902,1771,3021,8261,5461,2978271,3541,4611,5651,6302,0561,7911,8322,0182,0751,8211,7361,3481,9211,7361,4411,5641,5771,7802,0520000000000000000002040000002953603753904052104354504501002001001003002002002001006006006005002000
   > Long-term Liabilities 
600
500
100
0
-100
0
0
600
600
500
500
500
500
700
700
300
263
225
398
150
138
125
88
50
550
500
500
289
292
545
552
560
567
575
584
652
765
1,148
1,150
1,451
1,774
2,075
2,087
2,577
2,599
2,628
4,173
4,717
4,779
5,720
6,040
6,015
6,116
6,150
6,171
6,127
6,224
6,257
6,221
6,261
6,312
6,372
6,447
6,713
6,773
6,829
6,891
5,521
5,502
6,490
6,525
5,517
6,107
6,039
6,172
5,735
5,455
4,896
4,799
4,707
4,567
4,469
4,290
4,747
4,905
4,758
4,698
4,795
4,671
4,550
4,428
4,326
4,909
4,921
4,835
4,888
4,847
5,001
4,969
5,079
4,882
5,567
5,558
5,556
5,743
6,280
6,301
6,679
6,703
6,7036,6796,3016,2805,7435,5565,5585,5674,8825,0794,9695,0014,8474,8884,8354,9214,9094,3264,4284,5504,6714,7954,6984,7584,9054,7474,2904,4694,5674,7074,7994,8965,4555,7356,1726,0396,1075,5176,5256,4905,5025,5216,8916,8296,7736,7136,4476,3726,3126,2616,2216,2576,2246,1276,1716,1506,1166,0156,0405,7204,7794,7174,1732,6282,5992,5772,0872,0751,7741,4511,1501,148765652584575567560552545292289500500550508812513815039822526330070070050050050050060060000-1000100500600
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,550
4,428
4,326
4,909
4,921
4,835
4,889
4,847
5,001
4,969
5,079
4,882
5,567
5,558
5,556
5,743
6,280
6,301
0
0
006,3016,2805,7435,5565,5585,5674,8825,0794,9695,0014,8474,8894,8354,9214,9094,3264,4284,55000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,558
0
0
0
0
0
0
0000005,558000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
1,900
1,900
8,000
8,000
7,400
6,300
6,500
6,400
6,000
5,400
5,000
1,700
1,700
1,500
1,900
1,763
1,872
2,055
2,126
2,049
1,859
1,892
1,968
2,118
1,958
1,882
1,801
1,988
1,838
2,034
1,760
2,284
2,487
2,636
2,794
2,768
2,745
3,091
2,921
1,478
1,266
1,091
3,081
2,283
8,273
7,653
6,190
7,621
7,048
6,771
6,099
6,412
5,691
6,639
5,531
5,647
5,581
5,128
5,035
5,148
4,868
5,379
5,037
4,124
3,811
3,999
3,897
5,721
5,838
7,089
7,821
9,842
10,614
12,888
13,121
13,677
13,955
14,214
14,345
15,292
15,280
15,589
15,860
15,175
18,437
18,310
18,481
10,354
10,268
10,692
10,540
10,537
9,980
11,948
11,554
6,619
7,044
8,215
16,714
18,556
22,198
23,814
24,745
24,939
23,461
23,365
22,643
24,624
27,226
27,22624,62422,64323,36523,46124,93924,74523,81422,19818,55616,7148,2157,0446,61911,55411,9489,98010,53710,54010,69210,26810,35418,48118,31018,43715,17515,86015,58915,28015,29214,34514,21413,95513,67713,12112,88810,6149,8427,8217,0895,8385,7213,8973,9993,8114,1245,0375,3794,8685,1485,0355,1285,5815,6475,5316,6395,6916,4126,0996,7717,0487,6216,1907,6538,2732,2833,0811,0911,2661,4782,9213,0912,7452,7682,7942,6362,4872,2841,7602,0341,8381,9881,8011,8821,9582,1181,9681,8921,8592,0492,1262,0551,8721,7631,9001,5001,7001,7005,0005,4006,0006,4006,5006,3007,4008,0008,0001,9001,900
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,804
19,425
19,457
20,704
20,711
20,702
21,264
21,381
0
0
22,571
0
0
0
24,300
24,300
24,300
24,300
24,300
24,987
25,532
27,662
28,398
30,990
30,990
30,990
31,522
31,522
31,522
31,299
31,299
31,299
31,299
31,299
33,965
33,965
34,020
33,912
33,912
33,912
33,912
33,912
33,912
35,357
35,357
35,357
35,667
36,109
42,216
43,610
47,465
48,948
49,127
49,919
49,655
49,341
49,097
0
0
0049,09749,34149,65549,91949,12748,94847,46543,61042,21636,10935,66735,35735,35735,35733,91233,91233,91233,91233,91233,91234,02033,96533,96531,29931,29931,29931,29931,29931,52231,52231,52230,99030,99030,99028,39827,66225,53224,98724,30024,30024,30024,30024,30000022,5710021,38121,26420,70220,71120,70419,45719,42518,80400000000000000000000000000000000000000000000000000
   Retained Earnings 
400
500
500
400
-200
-1,300
-1,600
-1,700
-2,100
-2,700
-3,000
-6,300
-6,300
-6,700
-6,600
-6,775
-6,689
-6,583
-6,512
-6,534
-6,724
-6,690
-6,614
-6,464
-6,628
-6,706
-6,808
-6,828
-6,978
-7,034
-7,310
-6,814
-7,383
-7,250
-7,184
-7,297
-7,403
-7,680
-7,913
-9,389
-9,871
-10,346
-11,287
-12,101
-13,114
-14,444
-15,329
-15,769
-16,352
-16,865
-17,538
-18,253
-18,993
-19,570
-20,821
-20,792
-21,526
-22,155
-22,900
-23,406
-23,923
-24,533
-25,493
-25,948
-26,650
-26,480
-26,582
-24,828
-24,712
-24,518
-24,308
-24,659
-24,657
-24,530
-24,448
-24,045
-24,384
-24,208
-24,160
-23,297
-26,513
-26,256
-26,067
-27,077
-27,171
-27,513
-27,513
-35,698
-35,818
-35,426
-35,618
-35,666
-36,252
-36,471
-36,911
-41,894
-41,763
-40,956
-39,440
-38,661
-37,780
-37,046
-36,408
-36,872
-38,171
-38,140
-38,909
-36,911
-34,456
-34,456-36,911-38,909-38,140-38,171-36,872-36,408-37,046-37,780-38,661-39,440-40,956-41,763-41,894-36,911-36,471-36,252-35,666-35,618-35,426-35,818-35,698-27,513-27,513-27,171-27,077-26,067-26,256-26,513-23,297-24,160-24,208-24,384-24,045-24,448-24,530-24,657-24,659-24,308-24,518-24,712-24,828-26,582-26,480-26,650-25,948-25,493-24,533-23,923-23,406-22,900-22,155-21,526-20,792-20,821-19,570-18,993-18,253-17,538-16,865-16,352-15,769-15,329-14,444-13,114-12,101-11,287-10,346-9,871-9,389-7,913-7,680-7,403-7,297-7,184-7,250-7,383-6,814-7,310-7,034-6,978-6,828-6,808-6,706-6,628-6,464-6,614-6,690-6,724-6,534-6,512-6,583-6,689-6,775-6,600-6,700-6,300-6,300-3,000-2,700-2,100-1,700-1,600-1,300-200400500500400
   Accumulated Other Comprehensive Income 
-500
-500
-500
-600
-600
-600
-600
-900
-900
-900
-900
-1,100
-1,100
-1,100
-1,100
-936
-936
0
-936
-1,076
-1,076
-1,076
-1,076
-1,215
-1,215
-1,215
21
228
228
479
479
505
1,181
1,181
1,247
1,228
1,310
1,004
1,004
974
1,197
1,421
1,421
1,353
1,353
1,353
1,353
3,172
3,172
-2,912
-2,967
-2,511
-2,619
-2,729
-2,839
-2,872
-2,970
-3,068
-3,166
-3,237
-3,322
-3,403
-3,487
-3,573
-3,652
-3,734
-3,814
-3,524
-3,596
-3,579
-3,658
-3,737
-3,814
-3,892
-3,975
-4,060
-4,137
-4,216
-4,295
-4,378
-4,454
-4,532
-4,614
-4,698
-4,792
-4,897
-5,004
-4,926
-5,031
-5,137
-5,246
-5,356
-5,485
-5,622
-5,765
-5,907
-6,046
0
0
0
0
0
0
0
0
0
0
0
0
000000000000-6,046-5,907-5,765-5,622-5,485-5,356-5,246-5,137-5,031-4,926-5,004-4,897-4,792-4,698-4,614-4,532-4,454-4,378-4,295-4,216-4,137-4,060-3,975-3,892-3,814-3,737-3,658-3,579-3,596-3,524-3,814-3,734-3,652-3,573-3,487-3,403-3,322-3,237-3,166-3,068-2,970-2,872-2,839-2,729-2,619-2,511-2,967-2,9123,1723,1721,3531,3531,3531,3531,4211,4211,1979741,0041,0041,3101,2281,2471,1811,18150547947922822821-1,215-1,215-1,215-1,076-1,076-1,076-1,076-9360-936-936-1,100-1,100-1,100-1,100-900-900-900-900-600-600-600-600-500-500-500
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,302
9,342
9,388
9,415
10,158
10,204
10,253
10,237
10,158
11,034
10,703
9,609
9,640
9,754
9,619
9,705
9,892
10,182
0
0
0010,1829,8929,7059,6199,7549,6409,60910,70311,03410,15810,23710,25310,20410,1589,4159,3889,3429,30200000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
2,000
1,900
8,000
8,200
8,200
8,200
8,700
9,000
9,000
9,000
8,900
9,100
9,100
9,300
9,600
9,474
9,497
8,638
9,574
9,659
9,659
9,659
9,659
9,797
8,586
8,588
8,588
8,588
8,589
8,589
8,591
8,592
8,689
8,705
8,731
8,837
8,838
9,768
9,831
9,894
9,940
10,017
12,947
13,030
20,033
20,743
20,166
20,218
20,229
23,637
4,833
5,241
5,227
5,504
5,642
5,736
5,844
5,903
27,935
28,553
6,220
29,912
30,531
30,072
6,161
6,180
6,180
6,250
6,250
6,620
6,596
6,839
6,873
6,428
6,579
6,732
6,816
6,899
6,982
7,289
10,494
10,545
10,628
10,952
11,643
11,858
11,973
12,139
12,173
12,206
12,245
12,291
12,319
13,062
13,108
13,156
13,140
13,062
13,938
13,607
12,513
11,912
12,026
11,892
11,977
12,164
2,273
0
0
002,27312,16411,97711,89212,02611,91212,51313,60713,93813,06213,14013,15613,10813,06212,31912,29112,24512,20612,17312,13911,97311,85811,64310,95210,62810,54510,4947,2896,9826,8996,8166,7326,5796,4286,8736,8396,5966,6206,2506,2506,1806,1806,16130,07230,53129,9126,22028,55327,9355,9035,8445,7365,6425,5045,2275,2414,83323,63720,22920,21820,16620,74320,03313,03012,94710,0179,9409,8949,8319,7688,8388,8378,7318,7058,6898,5928,5918,5898,5898,5888,5888,5888,5869,7979,6599,6599,6599,6599,5748,6389,4979,4749,6009,3009,1009,1008,9009,0009,0009,0008,7008,2008,2008,2008,0001,9002,000



Balance Sheet

Currency in CAD. All numbers in thousands.




Cash Flow

Currency in CAD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2023-09-30)

Gross Profit (+$)
totalRevenue16,515
Cost of Revenue-9,033
Gross Profit7,4817,481
 
Operating Income (+$)
Gross Profit7,481
Operating Expense-19,251
Operating Income-2,736-11,770
 
Operating Expense (+$)
Research Development2,047
Selling General Administrative8,010
Selling And Marketing Expenses0
Operating Expense19,25110,057
 
Net Interest Income (+$)
Interest Income458
Interest Expense-839
Other Finance Cost-0
Net Interest Income-382
 
Pretax Income (+$)
Operating Income-2,736
Net Interest Income-382
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-39-5,815
EBIT - interestExpense = -839
-39
800
Interest Expense839
Earnings Before Interest and Taxes (EBIT)0800
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-39
Tax Provision-0
Net Income From Continuing Ops-39-39
Net Income-39
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net3,079382
 

Technical Analysis of Microbix
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Microbix. The general trend of Microbix is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Microbix's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Microbix Biosystems Inc..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.37 < 0.37 < 0.37.

The bearish price targets are: 0.35 > 0.33 > 0.33.

Tweet this
Microbix Biosystems Inc. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Microbix Biosystems Inc.. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Microbix Biosystems Inc. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Microbix Biosystems Inc.. The current macd is -0.00534967.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Microbix price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Microbix. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Microbix price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Microbix Biosystems Inc. Daily Moving Average Convergence/Divergence (MACD) ChartMicrobix Biosystems Inc. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Microbix Biosystems Inc.. The current adx is 8.8633076.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Microbix shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Microbix Biosystems Inc. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Microbix Biosystems Inc.. The current sar is 0.42032496.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Microbix Biosystems Inc. Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Microbix Biosystems Inc.. The current rsi is 39.45. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Microbix Biosystems Inc. Daily Relative Strength Index (RSI) ChartMicrobix Biosystems Inc. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Microbix Biosystems Inc.. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Microbix price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Microbix Biosystems Inc. Daily Stochastic Oscillator ChartMicrobix Biosystems Inc. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Microbix Biosystems Inc.. The current cci is -174.07407407.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Microbix Biosystems Inc. Daily Commodity Channel Index (CCI) ChartMicrobix Biosystems Inc. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Microbix Biosystems Inc.. The current cmo is -27.90940231.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Microbix Biosystems Inc. Daily Chande Momentum Oscillator (CMO) ChartMicrobix Biosystems Inc. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Microbix Biosystems Inc.. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Microbix Biosystems Inc. Daily Williams %R ChartMicrobix Biosystems Inc. Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Microbix Biosystems Inc..

Microbix Biosystems Inc. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Microbix Biosystems Inc.. The current atr is 0.01054855.

Microbix Biosystems Inc. Daily Average True Range (ATR) ChartMicrobix Biosystems Inc. Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Microbix Biosystems Inc.. The current obv is -554,412.

Microbix Biosystems Inc. Daily On-Balance Volume (OBV) ChartMicrobix Biosystems Inc. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Microbix Biosystems Inc.. The current mfi is 33.50.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Microbix Biosystems Inc. Daily Money Flow Index (MFI) ChartMicrobix Biosystems Inc. Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Microbix Biosystems Inc..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-09ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-17CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-22MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-30ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-13BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-20MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.

6.3. Candlestick Patterns

Microbix Biosystems Inc. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Microbix Biosystems Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.453
Ma 20Greater thanMa 500.382
Ma 50Greater thanMa 1000.393
Ma 100Greater thanMa 2000.364
OpenGreater thanClose0.370
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Microbix with someone you think should read this too:
  • Are you bullish or bearish on Microbix? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Microbix? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Microbix Biosystems Inc.

I send you an email if I find something interesting about Microbix Biosystems Inc..


Comments

How you think about this?

Leave a comment

Stay informed about Microbix Biosystems Inc..

Receive notifications about Microbix Biosystems Inc. in your mailbox!